CONCENTRATION-DEPENDENT TUBULAR SECRETION OF ACETAZOLAMIDE AND ITS INHIBITION BY SALICYLIC-ACID IN THE ISOLATED-PERFUSED RAT-KIDNEY

Citation
Dr. Taft et al., CONCENTRATION-DEPENDENT TUBULAR SECRETION OF ACETAZOLAMIDE AND ITS INHIBITION BY SALICYLIC-ACID IN THE ISOLATED-PERFUSED RAT-KIDNEY, Drug metabolism and disposition, 24(4), 1996, pp. 456-461
Citations number
27
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00909556
Volume
24
Issue
4
Year of publication
1996
Pages
456 - 461
Database
ISI
SICI code
0090-9556(1996)24:4<456:CTSOAA>2.0.ZU;2-3
Abstract
An isolated perfused rat kidney (IPK) technique was used to study the effect of salicylic acid (SA) on the excretion of acetazolamide (AZ), Initial experiments were conducted in the absence of interactants at t hree nominal AZ concentrations (50, 100, and 250 mu g/ml). Over the co ncentration range studied, AZ demonstrated net tubular secretion in th e IPK, Significant decreases in excretion ratio (4.97 +/- 0.79-2.66 +/ - 1.1) and secretory clearance (0.809 +/- 0.23-0.541 +/- 0.28) were ob served with increasing AZ concentration, consistent with saturation of tubular secretion, Using a facilitated model for renal secretion, val ues of tubular transport parameters were obtained from a plot of excre tion ratio vs. unbound AZ concentration: t(max) = 118 +/- 29.4 mu g/mi n, K-M = 53.4 +/- 22.4 mu g/ml, and t(max(A)) = 6.31 +/- 2.82 mu g/min , In the presence of SA (200 mu g/ml), renal secretion of AZ was inhib ited, as demonstrated by significant decreases in renal clearance (0.7 31 +/- 0.21-0.147 +/- 0.03) and excretion ratio (3.77 +/- 0.82-0.378 /- 0.07). Although these findings were indicative of a reabsorption co mponent to AZ excretion in the IPK that had not been previously propos ed, the results were consistent with a previous investigation of conco mitant administration of AZ and SA in humans (Br. J. Clin, Pharmacol. 27, 866, 1989), thereby endorsing utilization of the IPK as a screenin g tool for renal clearance mechanisms in humans.